Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshinori Miyata

Erratum To: UDP-glucuronosyltransferase 1A16 and 28 Polymorphisms as Indicators of Initial Dose Level of Irinotecan to Reduce Risk of Neutropenia in Patients Receiving FOLFIRI for Colorectal Cancer

International Journal of Clinical Oncology

English

Long-Term Results for Patients With Unresectable Gastric Cancer Who Received Chemotherapy in the Japan Clinical Oncology Group (JCOG) Trials

English

Related publications

Ligand Orientation Governs Conjugation Capacity of UDP-glucuronosyltransferase 1A1

Journal of Biochemistry

English

Pharmacogenetic Clinical Randomised Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI With High-Dose Irinotecan (HD-FOLFIRI) in Metastatic Colorectal Cancer Patients According to Their UGT1A 1 Genotype

British Journal of Cancer

Cancer Research

Oncology

2018

English

Variations in the UDP-glucuronosyltransferase 1A1 Gene for the Development of Unconjugated Hyperbilirubinemia in Taiwanese

English

Role of Cysteine Residues in the Function of Human UDP Glucuronosyltransferase Isoform 1A1 (UGT1A1)

English

FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms

English

Response to Regorafenib at an Initial Dose of 120 Mg as Salvage Therapy for Metastatic Colorectal Cancer

Molecular and Clinical Oncology

Cancer Research

Oncology

2017

English

Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer

Clinical Gastroenterology and Hepatology

Hepatology

Gastroenterology

2019

English

MicroRNA Polymorphisms and Risk of Colorectal Cancer

Cancer Epidemiology Biomarkers and Prevention

English

Molecular Probes for Identification of UDP-glucuronosyltransferase 1 Gene Polymorphisms for Gilbert's Syndrome Diagnosis

Biomedical Research

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshinori Miyata

Erratum To: UDP-glucuronosyltransferase 1A1*6 and *28 Polymorphisms as Indicators of Initial Dose Level of Irinotecan to Reduce Risk of Neutropenia in Patients Receiving FOLFIRI for Colorectal Cancer

Long-Term Results for Patients With Unresectable Gastric Cancer Who Received Chemotherapy in the Japan Clinical Oncology Group (JCOG) Trials

Related publications

Ligand Orientation Governs Conjugation Capacity of UDP-glucuronosyltransferase 1A1

Pharmacogenetic Clinical Randomised Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI With High-Dose Irinotecan (HD-FOLFIRI) in Metastatic Colorectal Cancer Patients According to Their UGT1A 1 Genotype

Variations in the UDP-glucuronosyltransferase 1A1 Gene for the Development of Unconjugated Hyperbilirubinemia in Taiwanese

Role of Cysteine Residues in the Function of Human UDP Glucuronosyltransferase Isoform 1A1 (UGT1A1)

FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms

Response to Regorafenib at an Initial Dose of 120 Mg as Salvage Therapy for Metastatic Colorectal Cancer

Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer

MicroRNA Polymorphisms and Risk of Colorectal Cancer

Molecular Probes for Identification of UDP-glucuronosyltransferase 1 Gene Polymorphisms for Gilbert's Syndrome Diagnosis

Erratum To: UDP-glucuronosyltransferase 1A16 and 28 Polymorphisms as Indicators of Initial Dose Level of Irinotecan to Reduce Risk of Neutropenia in Patients Receiving FOLFIRI for Colorectal Cancer